ATAI
Atai Beckley NV
NASDAQ · Healthcare · Medical - Pharmaceuticals · NL
$7.35
+0.00%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $400.0K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.09
- EPS estimate
- -$0.11
- Revenue actual
- $1.7M
- Revenue estimate
- $770.8K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -8.0%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $7.75
- PT range
- $7.50 – $8.00
- Analysts
- 8
0 Buy8 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.11 | -$0.09 | Beat 15.64% | $1.7M |
| May 12, 2026 | -$0.11 | -$0.08 | Beat 27.27% | $954.0K |
| Mar 6, 2026 | -$0.12 | -$0.05 | Beat 58.33% | $1.1M |
| Nov 12, 2025 | -$0.12 | -$0.28 | Miss -133.33% | $749.0K |
| Aug 14, 2025 | -$0.12 | -$0.14 | Miss -16.67% | $719.0K |
| May 14, 2025 | -$0.19 | -$0.15 | Beat 21.05% | $1.6M |
| Mar 17, 2025 | -$0.14 | -$0.24 | Miss -71.43% | -$5.0K |
| Aug 13, 2024 | -$0.17 | -$0.36 | Miss -111.76% | $273.0K |
| May 15, 2024 | -$0.20 | -$0.17 | Beat 15.00% | — |
| Nov 14, 2023 | -$0.20 | -$0.14 | Beat 30.00% | $87.0K |
| Aug 10, 2023 | -$0.21 | -$0.21 | In line | $172.0K |
| May 11, 2023 | -$0.22 | -$0.21 | Beat 4.55% | $37.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026